Citadel Advisors’s GP-Act III Acquisition Corp GPAT Stock Holding History
Bought
Maintained
Sold
Other funds holding GPAT
KIM
FTCM
AIMCA
AA
PMAM
MI
LP
PAMP
WC
Citadel Advisors's GPAT Position: Q1 2026 in Review
Citadel Advisors increased its GP-Act III Acquisition Corp (GPAT) stake by 15% in Q1 2026, buying an estimated $24.4K and bringing the position to 17,172 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #11476.
Citadel Advisors first reported a position in GPAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $199K in Q3 2025. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.
- Citadel Advisors held 17,172 shares of GP-Act III Acquisition Corp worth $186K as of Q1 2026.
- Citadel Advisors bought 2,263 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $24.4K.
- GP-Act III Acquisition Corp made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11476 holding.
- Citadel Advisors first reported a position in GP-Act III Acquisition Corp in Q4 2024 and has held it in 6 quarters since.
- Citadel Advisors's GP-Act III Acquisition Corp position peaked at $199K in Q3 2025.
- 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.